(AVXL) Anavex Life Sciences - Performance 157.5% in 12m
AVXL performance: live returns, drawdowns, peer ranking & SPY comparison from 1w to 5y, all in one clean chart-driven dashboard.
Performance Rating
30.82%
#13 in Peer-Group
Rel. Strength
96.51%
#269 in Stock-Universe
Total Return 12m
157.52%
#9 in Peer-Group
Total Return 5y
132.04%
#7 in Peer-Group
| P/E | Value |
|---|---|
| P/E Trailing | - |
| P/E Forward | 4.59 |
| High / Low | USD |
|---|---|
| 52 Week High | 13.46 USD |
| 52 Week Low | 4.12 USD |
| Sentiment | Value |
|---|---|
| VRO Trend Strength +-100 | 96.03 |
| Buy/Sell Signal +-5 | 0.84 |
| Support / Resistance | Levels |
|---|---|
| Support | |
| Resistance |
12m Total Return: AVXL (157.5%) vs XBI (-7%)
5y Drawdown (Underwater) Chart
Top Performer in Biotechnology
Overall best picks of Peer Group - Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability | EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| GILD NASDAQ Gilead Sciences |
3.23% | 73% | 77.8% | 22.7 | 13.6 | 0.23 | 28.3% | -3.71% |
| UTHR NASDAQ United Therapeutics |
-9.1% | -6.38% | 147% | 11.3 | 10.5 | 1.43 | 74.6% | 16.1% |
| AMGN NASDAQ Amgen |
3.91% | -0.97% | 36% | 25.4 | 13.4 | 0.93 | 0.60% | 41% |
| BIM PA Biomerieux |
1.34% | 27.6% | -4.82% | 33.1 | 25.8 | 1.55 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
3.69% | -7.17% | 1.14% | 43 | 24.8 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
18.3% | 43% | -4.19% | 27.6 | 22.4 | 0.9 | 68.9% | 36.8% |
| PTCT NASDAQ PTC Therapeutics |
-4.03% | 58.7% | -9.25% | 7.71 | 6.26 | 0.81 | - | 68% |
| ERF PA Eurofins Scientific SE |
6.2% | 28.7% | 15.2% | 28.9 | 15.4 | 0.64 | -62.1% | -19.3% |
Performance Comparison: AVXL vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for AVXL
| Total Return (including Dividends) | AVXL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 39.77% | 3.36% | 5.25% |
| 3 Months | 31.75% | 15.73% | 24.13% |
| 12 Months | 157.52% | -7.02% | 14.15% |
| 5 Years | 132.04% | -24.21% | 111.83% |
| Trend Score (consistency of price movement) | AVXL | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 92.9% | 4.4% | 81% |
| 3 Months | 4.4% | 78.8% | 96.9% |
| 12 Months | 62.6% | -85.8% | 44.9% |
| 5 Years | -27.4% | -52.6% | 84% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
|---|---|---|---|
| 1 Month | %th94.00 | 35.23% | 32.80% |
| 3 Month | %th64.50 | 13.84% | 6.14% |
| 12 Month | %th96.50 | 176.97% | 125.59% |
| 5 Years | %th97.50 | 206.17% | 9.54% |
FAQs
Does Anavex Life Sciences (AVXL) outperform the market?
Yes,
over the last 12 months AVXL made 157.52%, while its related Sector, the SPDR S&P Biotech (XBI) made -7.02%.
Over the last 3 months AVXL made 31.75%, while XBI made 15.73%.
Performance Comparison AVXL vs Indeces and Sectors
Above 0 means better perfomance compared to Symbol in this Timeframe
AVXL vs. Indices
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | 12.1% | 34.5% | -23.4% | 143% |
| US NASDAQ 100 | QQQ | 12.3% | 34.5% | -24% | 145% |
| German DAX 40 | DAX | 14.3% | 41.2% | -35.5% | 129% |
| Shanghai Shenzhen CSI 300 | CSI 300 | 12.3% | 36.5% | -26.8% | 138% |
| Hongkong Hang Seng | HSI | 12.5% | 33.7% | -42.8% | 119% |
| India NIFTY 50 | INDA | 14% | 36.3% | -23.7% | 158% |
| Brasil Bovespa | EWZ | 9.7% | 31% | -48.4% | 147% |
AVXL vs. Sectors
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | 13.5% | 33.9% | -27.5% | 133% |
| Consumer Discretionary | XLY | 12.6% | 36.6% | -15.7% | 140% |
| Consumer Staples | XLP | 11.8% | 39.1% | -25% | 149% |
| Energy | XLE | 11.8% | 32.7% | -19.3% | 158% |
| Financial | XLF | 11.4% | 34.7% | -28.3% | 128% |
| Health Care | XLV | 12.7% | 37.6% | -16% | 162% |
| Industrial | XLI | 12% | 35.6% | -31.2% | 132% |
| Materials | XLB | 9.9% | 35.5% | -27.9% | 152% |
| Real Estate | XLRE | 12.2% | 38.8% | -23.1% | 145% |
| Technology | XLK | 11.4% | 31.1% | -25.7% | 146% |
| Utilities | XLU | 13.2% | 38% | -26.6% | 135% |
| Aerospace & Defense | XAR | 14.2% | 32.7% | -41.9% | 108% |
| Biotech | XBI | 11.1% | 36.4% | -10.2% | 165% |
| Homebuilder | XHB | 9.6% | 32.8% | -16.2% | 152% |
| Retail | XRT | 9.6% | 34.8% | -19.1% | 146% |
AVXL vs. Commodities
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Oil | USO | 11.2% | 31.3% | -15.0% | 165% |
| Natural Gas | UNG | 21.6% | 49.6% | -6.6% | 160% |
| Gold | GLD | 11.9% | 41% | -44% | 119% |
| Silver | SLV | 11.1% | 32.9% | -40.7% | 140% |
| Copper | CPER | 13.1% | 35.2% | -40.4% | 147% |
AVXL vs. Bonds
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| iShares 20+ Years Bond | TLT | 13.9% | 38.7% | -19.9% | 160% |
| iShares High Yield Corp. Bond | HYG | 13.3% | 38.2% | -22.3% | 148% |